| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| INFINITUM ASSET MANAGEMENT, LLC | 9.9% | $75,318,874 | 3,418,923 | INFINITUM ASSET MANAGEMENT, LLC | 01 May 2025 | |||
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.9% | $75,183,720 | 3,412,788 | Suvretta Capital Management, LLC | 30 Jun 2025 | |||
| FMR LLC | 8.4% | $62,870,983 | 3,407,549 | FMR LLC | 30 Sep 2025 | |||
| ORBIMED ADVISORS LLC | 7.5% | $66,692,036 | 3,027,328 | ORBIMED ADVISORS LLC | 11 Aug 2025 | |||
| BlackRock, Inc. | 5.6% | +14% | $46,667,692 | +$6,277,844 | 2,319,341 | +16% | BlackRock, Inc. | 31 Dec 2025 |
| HBM Healthcare Investments (Cayman) Ltd. | 5.4% | $40,491,643 | 2,195,014 | HBM Healthcare Investments (Cayman) Ltd. | 08 Oct 2025 | |||
| VANGUARD GROUP INC | 5% | $37,445,862 | 2,029,531 | The Vanguard Group | 30 Sep 2025 | |||
| Octagon Capital Advisors LP | 4.9% | $36,365,946 | 1,971,054 | Octagon Capital Advisors LP | 30 Sep 2025 |
As of 30 Sep 2025, 104 institutional investors reported holding 38,570,342 shares of ArriVent BioPharma, Inc. - Common Stock (AVBP). This represents 93% of the company’s total 41,416,804 outstanding shares.
The largest institutional shareholders of ArriVent BioPharma, Inc. - Common Stock (AVBP) together control 88% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| HHLR ADVISORS, LTD. | 11% | 4,484,672 | 0% | 2% | $82,742,198 |
| INFINITUM ASSET MANAGEMENT, LLC | 9.3% | 3,868,923 | +13% | 13% | $71,381,629 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 8.9% | 3,703,452 | +8.5% | 2.1% | $68,328,689 |
| FMR LLC | 8.2% | 3,407,549 | +66% | 0% | $62,869,279 |
| ORBIMED ADVISORS LLC | 7.3% | 3,027,328 | 0% | 1.3% | $55,854,202 |
| BlackRock, Inc. | 4.9% | 2,046,138 | +11% | 0% | $37,751,246 |
| VANGUARD GROUP INC | 4.9% | 2,029,531 | +37% | 0% | $37,444,847 |
| Octagon Capital Advisors LP | 4.8% | 1,971,054 | +1.3% | 5.7% | $36,365,946 |
| NOVO HOLDINGS A/S | 4.7% | 1,942,142 | +3.7% | 2.3% | $35,832,520 |
| Sofinnova Investments, Inc. | 4.1% | 1,696,752 | 0% | 1.9% | $31,305,074 |
| General Catalyst Group Management, LLC | 3.6% | 1,494,786 | 0% | 0.91% | $27,578,802 |
| STATE STREET CORP | 2.5% | 1,027,628 | +39% | 0% | $18,959,737 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7% | 716,288 | +20% | 0% | $13,217,952 |
| Siren, L.L.C. | 1.7% | 700,000 | 0% | 0.51% | $12,915,000 |
| HSG Holding Ltd | 1.6% | 663,308 | 0% | 0.68% | $12,994,204 |
| Fund 1 Investments, LLC | 1.5% | 619,851 | +17% | 1.4% | $11,436,251 |
| UBS Group AG | 1.2% | 497,601 | +475% | 0% | $9,180,738 |
| GOLDMAN SACHS GROUP INC | 1% | 431,939 | +27% | 0% | $7,969,274 |
| COOPERMAN LEON G | 1% | 421,278 | 0% | 0.24% | $7,772,579 |
| MORGAN STANLEY | 0.95% | 392,022 | +287% | 0% | $7,232,806 |
| Hidden Lake Asset Management LP | 0.76% | 314,036 | -48% | 2.3% | $5,793,964 |
| Woodline Partners LP | 0.72% | 296,916 | +102% | 0.03% | $5,478,100 |
| MILLENNIUM MANAGEMENT LLC | 0.69% | 286,104 | +62% | 0% | $5,278,619 |
| FRANKLIN RESOURCES INC | 0.62% | 256,422 | 0% | $4,730,986 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.59% | 243,486 | +29% | 0% | $4,492,317 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 84,687 | $1,703,991 | +$941,420 | $20.12 | 7 |
| 2025 Q3 | 38,570,342 | $712,380,900 | +$89,390,869 | $18.45 | 104 |
| 2025 Q2 | 33,625,800 | $732,036,140 | +$99,572,817 | $21.77 | 96 |
| 2025 Q1 | 29,075,127 | $539,323,391 | +$6,162,682 | $18.49 | 82 |
| 2024 Q4 | 28,465,885 | $757,455,987 | +$26,598,551 | $26.64 | 80 |
| 2024 Q3 | 25,909,614 | $612,333,484 | +$70,385,573 | $23.50 | 68 |
| 2024 Q2 | 20,990,668 | $389,375,916 | -$3,300,286 | $18.55 | 53 |
| 2024 Q1 | 21,851,940 | $388,890,872 | +$388,416,714 | $17.86 | 53 |